I was very happy to see some observations made by Dr. M instead of him staying in the shadows.  I take this as a very, very strong indication he is very pleased with the progress on both fronts.

The saying is to "follow the money" but for CTIX I think it could be changed to "follow Dr. M and LE".  If they are happy, we are happy.

As we now get to the crunch time re: MTD in the next couple of cohorts, should things slow a bit from one to the other so safety committee can do more analyzing of data, stay about the same, or possibly speed up?  Would love to have cohort 4 in the bag by ASCO.